New Animal Drugs; Change of Sponsor's Name and Address

Health and Human Services Department; Food and Drug Administration · 2011

Read New Animal Drugs; Change of Sponsor's Name and Address by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-17292.txt.

Description

Rule published in the Federal Register on 2011-07-11 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [FR Doc No: 2011-17292] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 [Docket No. FDA-2011-N-0003] New Animal Drugs; Change of Sponsor's Name and Address AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration.

Catalog record

CREATORHealth and Human Services Department; Food and Drug Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE4 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/07/11/2011-17292/new-animal-drugs-change-of-sponsors-name-and-address

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

New Animal Drugs; Change of Sponsor's Name and Address
Citation: us:fr:2011-17292
Creator: Health and Human Services Department; Food and Drug Administration
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/07/11/2011-17292/new-animal-drugs-change-of-sponsors-name-and-address
Context: Rule published in the Federal Register on 2011-07-11 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo).

[FR Doc No: 2011-17292]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 510

[Docket No. FDA-2011-N-0003]


New Animal Drugs; Change of Sponsor's Name and Address

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect a change of sponsor's name from Alpharma, 
LLC, to Alpharma, LLC, a wholly owned subsidiary of Pfizer, Inc. The 
sponsor's mailing address will also be changed.

DATES: This rule is effective July 11, 2011.

FOR FURTHER INFORMATION CONTACT: Steven D. Vaughn, Center for 
Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 
Standish Pl., Rockville, MD 20855, 240-276-8300, e-mail: 
[email protected].

SUPPLEMENTARY INFORMATION: Alpharma, LLC, 400 Crossing Blvd., 
Bridgewater, NJ 08807 has informed FDA of a change of name and mailing 
address to Alpharma, LLC, a wholly owned subsidiary of Pfizer, Inc., 
235 East 42d St., New York, NY 10017. Accordingly, the Agency is 
amending the regulations in 21 CFR 510.600(c) to reflect these changes.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


0
2. In Sec.  510.600, in the table in paragraph (c)(1), revise the entry 
for ``Alpharma LLC''; and in the table in paragraph (c)(2), revise the 
entry for ``046573'' to read as follows:


Sec.  510.600  Names, addresses, and drug labeler codes of sponsors of 
approved applications.

* * * * *
    (c) * * *
    (1) * * *

------------------------------------------------------------------------
                                                           Drug labeler
                  Firm name and address                        code
------------------------------------------------------------------------
 
                                * * * * *
Alpharma, LLC, a wholly owned subsidiary of Pfizer,               046573
 Inc., 235 East 42d St., New York, NY 10017.............
 
                                * * * * *
------------------------------------------------------------------------

     (2) * * *

------------------------------------------------------------------------
             Drug labeler code                  Firm name and address
------------------------------------------------------------------------
 
                                * * * * *
046573....................................  Alpharma, LLC, a wholly
                                             owned subsidiary of Pfizer,
                                             Inc., 235 East 42d St., New
                                             York, NY 10017
 
                                * * * * *
------------------------------------------------------------------------


    Dated: July 1, 2011.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug Evaluation, Center for 
Veterinary Medicine.
[FR Doc. 2011-17292 Filed 7-8-11; 8:45 am]

Read the complete text